Skip to main content
Swing Capital

Wanbury Ltd

NSE: WANBURY BSE: 524212Pharma

Incorporated in 1988, Wanbury Ltd is in the business of pharmaceutical and related activities, including research[1]

₹253
52W: ₹162 — ₹329
PE 13.7 · Book ₹30.7 · +724% vs book
Market Cap₹884 Cr
Stock P/E13.7Price to Earnings
ROCE33.9%Return on Capital
ROE66.9%Return on Equity
Div. Yield0%Face Value ₹10

Strengths

  • +Company has delivered good profit growth of 29.2% CAGR over last 5 years

Weaknesses

  • −Stock is trading at 8.12 times its book value
  • −Though the company is reporting repeated profits, it is not paying out dividend
  • −The company has delivered a poor sales growth of 10.3% over past five years.
  • −Tax rate seems low
  • −Promoters have pledged 62.2% of their holding.
  • −Company's cost of borrowing seems high

Shareholding Pattern

Promoters43.01%
FIIs0.59%
DIIs0%
Public56.39%
CategoryJun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Promoters39.79%39.77%▼0.039.76%▼0.039.76%39.63%▼0.143.09%▲3.543.08%▼0.043.01%▼0.1
FIIs0.22%1.02%▲0.80.84%▼0.21.55%▲0.71.59%▲0.00.82%▼0.80.72%▼0.10.59%▼0.1
DIIs0%0%0%0%0%0%0%0%
Public59.97%59.21%▼0.859.4%▲0.258.68%▼0.758.79%▲0.156.08%▼2.756.21%▲0.156.39%▲0.2

Financial Statements

MetricSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Sales144146139131161133172163160162
Expenses127124121120141120142139134136
Operating Profit17211811201430242627
OPM %12%15%13%8%12%10%17%15%16%16%
Net Profit710818120131516
EPS ₹2.253.142.470.322.450.376.184.14.354.52

AI Insights

Revenue Trend

TTM revenue at ₹658Cr, up 9.7% YoY. OPM at 16%.

Debt Position

Borrowings at ₹196Cr. Debt-to-equity ratio: 2.72x. High leverage — monitor closely.

Capex Cycle

CWIP at ₹13Cr (7% of fixed assets). Moderate ongoing capital expenditure.

Institutional Flow

DIIs: 0% (+0.00pp change). FIIs: 0.59% (+0.59pp change). Promoters hold 43.01%.

Margin & Efficiency

ROCE improving from 6% (Sep 2014) to 34% (Mar 2025). Working capital days: 4.

Valuation

PE 13.7x with 33.9% ROCE. Price is 724% above book value of ₹30.7. Dividend yield: 0%.

Recent Announcements